Talk:Mirtazapine
Appearance
(Redirected from Talk:California rocket fuel)
This is the talk page for discussing improvements to the Mirtazapine article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1Auto-archiving period: 2 months |
This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Mirtazapine.
|
This talk page is for discussion on how to improve the Mirtazapine article. If you would like to ask questions about the subject, please address them to the Reference desk. |
The contents of the California rocket fuel page were merged into Mirtazapine on July 2017. For the contribution history and old versions of the redirected page, please see its history; for the discussion at that location, see its talk page. |
Parts of this article read like an advert and its cardiac risk is understated when looking at geriatric mortality, the only research I could find
[edit]Mirtazapine is known to cause hyponatremia in some patients and is therefore is a potential slow sodium channel blocker with cardiac symptoms typically appearing around a month after treatment, it just isn't a "fast" sodium channel blocker. This is from one of many peer reviewed journals that actually bother to include Mirtazapine in safety studies. The results on safety are questionable beyond specific cases such as general risks of overdose in people with no co-morbidities or tcas and it's cardiac safety in general is questionable compared to ssris Maiakaat (talk) 12:12, 21 November 2023 (UTC)